UNSPSC 51442710: Technetium Tc-99m mertiatide or technetium 99mtc mertiatide

This classification denotes a radioconjugate with the molecular formula C8H8N3O5S.2NA.O.TC, often used in study renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36ITO9SKQJ. The term technetium (sup 99m)tc mertiatide is a U.S. FDA designation. Most nations schedule Technetium Tc-99m mertiatide or technetium 99mtc mertiatide under HS 28444030.

UNSPSC 51442710 Technetium Tc-99m mertiatide (Commodity) represents a narrow diagnostic imaging radiopharmaceutical with minimal recent state and local procurement activity. The code nominally covers this specific technetium-based radiopharmaceutical used in nuclear medicine imaging, yet recent state and local opportunities posted under this code do not reflect purchases of the drug itself. Instead, issuing bodies have tagged radiologic and X-ray equipment procurements—including radiologic equipment installation, X-ray machine extended warranties, and X-ray inspection system maintenance—under this code, indicating a significant mismatch between the code's intended scope and current state and local classification practice. This suggests either persistent cataloging error or that the code is being repurposed locally for broader diagnostic imaging categories.

The recent opportunities cluster in Florida counties and Arizona, with Maricopa County (Arizona) issuing IFB362910 for radiologic equipment and installation at three colleges (due October 22, 2026); Escambia County Correction (Florida) seeking extended warranty coverage for X-ray machines under sole-source procurement SSCORALM2526005 (closed August 19, 2026); and Broward County Aviation Department (Florida) issuing an RFI (BLD2132311F1, closed July 28, 2026) to determine sole-source availability for Rapiscan X-ray inspection system maintenance services. A fourth posting from Pasco County (Florida) for copper sulfate supplies appears entirely unrelated to the code's nominal scope. The code shows no evident activity from state health departments, clinical laboratories, hospital systems, or other end-users of radiopharmaceuticals themselves. Pursuit of this code for state and local opportunities is not recommended without clarification of local classification standards and direct engagement with issuing bodies to confirm actual procurement needs.